Skip to main content

and
  1. Article

    Open Access

    Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

    **aoge Gao, Pin Jiang, **aohuan Wei, Wei Zhang, Jiwei Zheng, Shishuo Sun in BMC Cancer (2023)

  2. Article

    Open Access

    Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

    Galectin-3 (Gal-3), the only chimeric β-galactosides-binding lectin, consists of Gal-3N (N-terminal regulatory peptide) and Gal-3C (C-terminal carbohydrate-recognition domain). Interestingly, Gal-3C could spe...

    **aoge Gao, Pin Jiang, **aohuan Wei, Wei Zhang, Jiwei Zheng, Shishuo Sun in BMC Cancer (2023)

  3. Article

    Open Access

    Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis

    Hepatocellular carcinoma (HCC) is the sixth-most common malignancy worldwide. Multiple previous studies have assessed the relationship between TM6SF2 gene polymorphism and the risk of develo** HCC, with disc...

    Shan Tang, **g Zhang, Ting-Ting Mei, Hai-Qing Guo, **n-Huan Wei in BMC Cancer (2019)